References
- Cursi IB, Silva RT, Succi IB, et al. Onychomycosis due to Neoscytalidium treated with oral terbinafine, ciclopirox nail lacquer and nail abrasion: a pilot study of 25 patients. Mycopathologia. 2013;175:75–82
- Downs AMR, Lear JT, Archer CB. Scytalidium hyalinum onychomycosis successfully treated with 5% amorolfine nail lacquer. Br J Dermatol. 1999;140:555
- Tosti A, Piraccini BM, Lorenzi S. Onychomycosis caused by nondermatophytic molds: clinical features and response to treatment of 59 cases. J Am Acad Dermatol. 2000;42:217–24
- Welsh O, Vera-Cabrera L, Welsh E. Onychomycosis. Clin Dermatol. 2010;28:151–9
- Gupta AK, Drummond-Main C, Cooper EA, et al. Systematic review of nondermatophyte mold onychomycosis: diagnosis, clinical types, epidemiology, and treatment. J Am Acad Dermatol. 2012;66:494–502
- Gupta AK, Paquet M, Simpson FC. Therapies for the treatment of onychomycosis. Clin Dermatol. 2013;31:544–54
- Machovart M, Menir P, Helenon R, et al. Scytalidium and scytalidiosis: what’s new in 2012? J Mycol Med. 2013;23:40–6
- Lahfa M, Bulai-Livideanu C, Baran R, et al. Efficacy, safety and tolerability of an optimized avulsion technique with ONYSTER® (40% urea ointment with plastic dressing) ointment compared to bifonazole-urea ointment for removal of the clinically infected nail in toenail onychomycosis: a randomized evaluator-blinded controlled study. Dermatology. 2013;226:5–12
- Ungpakorn R, Lohaprathan S, Reangchainam S. Prevalence of foot diseases in outpatients attending the Institute of Dermatology, Bangkok, Thailand. Clin Exp Dermatol. 2004;29:87–90
- Sergeev AY, Gupta AK, Sergeev YV. The Scoring Clinical Index for Onychomycosis (SCIO index). Skin Therapy Lett. 2002;7:6–7
- Scher RK, Tavakkol A, Sigurgeirsson B, et al. Onychomycosis: diagnosis and definition of cure. J Am Acad Dermatol. 2007;56:939–44
- Wanitphakdeedechaa R, Thanomkittia K, Bunyarataveja S, et al. Efficacy and safety of 1064-nm Nd:YAG laser in treatment of onychomycosis. J Dermatolog Treat. 2015;17:1–5
- Lacroix C, Feuilhade de Cahuvin M. In vitro activity of amphotericin B, itraconazole, voriconazole, posaconazole, caspofungin and terbinafine against Scytalidium dimidiatum and Scytalidium hyalinum clinical isolates. J Antimicrob Chemother. 2008;61:835–7
- Harman S, Ashbee HR, Evans EG. Testing of antifungal combinations against yeasts and dermatophytes. J Dermatolog Treat. 2004;15:104–7
- Carney C, Tosti A, Daniel R, et al. A new classification system for grading the severity of onychomycosis: Onychomycosis Severity Index. Arch Dermatol. 2011;147:1277–82
- Elsayed MMA. Development of topical therapeutics for management of onychomycosis and other nail disorders: a pharmaceutical perspective. J Control Release. 2015;199:132–44
- Shirwaikar AA, Thomas T, Shirwaikar A, et al. Treatment of onychomycosis: an update. Indian J Pharm Sci. 2008;70:710–14
- Flagothier C, Pierard-Franchimont C, Pierard GE. New insights into the effect of amorolfine nail lacquer. Mycoses. 2005;48:91–4